Molnupiravir for sale at a drugstore in Hanoi. (Photo: VNA)
Hanoi (VNS/VNA) - The Ministry of Health (MoH) has advised asymptomaticCOVID-19 patients to not use Molnupiravir as part of their treatment.
TheMoH said Molnupiravir should only be used to treat mild to moderate cases inpatients with at least one risk factor for severe disease progression.
Themedicine should only be used by COVID-19 patients with symptoms that havedeveloped for five days or less, and Molnupiravir should not be used for morethan five days consecutively. In particular, it should not be used for post orpre-exposure prophylaxis.
Theadvice came after local medical units reported that people have been flockingto buy the medicine to store in advance, or by people with COVID but withoutsymptoms
Theministry said that COVID-19 patients with mild symptoms should use the medicinewhen their saturation of peripheral oxygen (SpO2) is higher than 96 percent andthe respiratory rate is less than 20 times per minute.
Thosewith moderate symptoms should use the medicine when the SpO2 is at 94-96 percent,the respiratory rate is 20-25 times per minute, and when an x-ray lung lesionshows less than 50 percent.
Thosewith underlying diseases can also use the medicine, the ministry said.
Thedosage of the medicine is 800mg, two times a day, over five days.
Molnupiraviris not recommended for use during pregnancy. Breastfeeding women are told tonot breastfeed while using the medicine and for four days after the last doseof Molnupiravir.
Themedicine should also not be used on COVID-19 patients under 18 years old, as itcan affect the development of bones and cartilage.
Molnupiravircan affect sperm in men, therefore, a reliable method of contraception shouldbe used during treatment and for at least three months after the last dose ofMolnupiravir./.
Three pharmaceutical companies in Vietnam are planning to or are producing Molnupiravir pills to treat COVID-19 patients with mild or no symptoms, according to the Ministry of Health.
Prime Minister Pham Minh Chinh chaired a meeting on December 5 with ministries, sectors, and relevant sides to discuss COVID-19 vaccine and drug development, production technology transfer, and import.
An advisory council of the Ministry of Health (MoH) has proposed this ministry grant certificates of registration for conditional circulation of three medicines containing the active ingredient molnupiravir for COVID-19 treatment.
The Drug Administration of Vietnam (DAV) under the Ministry of Health on February 17 issued the list of three COVID-19 treatment drugs containing the active ingredient Molnupiravir, which had been granted certificates of registration for conditional circulation.
The Drug Administration of Vietnam (DAV) under the Ministry of Health (MoH) has announced the prices of COVID-19 treatment drugs containing active ingredient Molnupiravir produced by three Vietnamese manufacturers.
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
Despite the ongoing global circulation and unpredictable developments of SARS-CoV-2, the World Health Organisation (WHO) hasn’t issued new warnings about COVID-19, said the Ministry of Health.
Molnupiravir for sale at a drugstore in Hanoi. (Photo: VNA) 
